News
Dr Vinay Prasad will return to head the FDA’s Center for Biologics Evaluation and Research less than 2 weeks after being ousted.
No matter what regulatory decisions Dr. Vinay Prasad makes moving forward, the fact that he was willing to legitimize and ...
Robert F. Kennedy’s right-hand man was briefly Laura Loomer’s latest scalp, but had his job saved thanks to the intervention ...
Trump loyalist Laura Loomer is openly campaigning to blunt Health and Human Services Secretary Robert F. Kennedy Jr.’s ...
For more on Prasad’s return, go here; for a “Matt’s Take” on Prasad, go here; for the latest on investors’ attitudes toward ...
Scientists are warning people that it isn't just covid vaccines that will be affected. In other vaccine news: RFK Jr.'s criticisms of the hepatitis B vaccine; updates on Vinay Prasad; and successful ...
2dOpinion
Drug Approvals Hit an FDA Wall
Therapies for rare and deadly disease are dying in Marty Makary’s shop.
Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues
CBER Chief Vinay Prasad reclaimed his job less than two weeks after his mysterious exit; MAHA implementor Gray Delany is out ...
Pharmaceutical Technology on MSN3d
Prasad’s shock FDA return reignites regulatory uncertainty
Vinay Prasad resumes leadership at the FDA’s CBER two weeks after he resigned amid cell and gene therapy controversy.
This episode of Pharma Pulse covers Vinay Prasad’s return to lead the FDA’s biologics center after a brief resignation, new ...
Health and Me on MSN4d
FDA Vaccination Chief Vinay Prasad Returns To Job Within Days After Quitting Under Pressure, Who Is He?
Dr. Vinay Prasad, ousted as FDA’s top vaccine and gene therapy regulator amid political backlash, has been reinstated. Known ...
WASHINGTON, DC – Dr. Vinay Prasad has been reinstated to a senior position at the Food and Drug Administration, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback